The stars of Europe's equity market The stars of Europe's equity market The stars of Europe's equity market

The stars of Europe's equity market

Equities 5 minutes to read
Peter Garnry

Chief Investment Strategist

Summary:  European equities have been the key story in equity markets since early 2022 when the interest rate shock started and inflation turned out to be higher for longer. Not only are European equities outperforming but they are also much more attractive on valuation priced at a P/E ratio of 13.2x compared to 18.5x for US equities. Earnings estimates have also been rising faster this year in Europe compared to the US and this is despite of all the hype about AI. In this equity note we also highlight which 20 European stocks that have contributed most to the outperformance this year.


Key points in this equity note:

  • European equities continue to outperform US equities on top of still being much cheaper on P/E and dividend yield.
  • 12-month earnings estimates on European equities are outpacing US earnings estimates this year.
  • Europe’s stars in the equity market this year have been stocks such as LVMH, Novo Nordisk, and ASML.

European equities continue to shine over US equities

European equities are up 14% this year compared to 8.5% for US equities. If it had not been for the AI hype the numbers would have been even more in favour of European equities. If compare the price change this year to the actual change in underlying earnings and even more importantly the expected earnings then the US equity market has gotten even more expensive relative to European equities. STOXX 600 is currently priced at a forward P/E ratio of 13.2x and dividend yield of 3.5% compared to 18.5x and 1.7% respectively. The risk-reward ratio is clearly in favour of European equities and many US investors are looking to diversify their US exposure with more weight to Europe and Japan. For more perspective on Japanese equities read our recent equity note Will the sun rise over Japanese equities?

It is clear by now that in the age of inflation, European equities have just been better. Since the Covid vaccines were announced unleashing the comeback of the physical world and inflation, European equities have returned 39% compared to 32% for US equities. Since the peak in equities in late 2021, US equities have declined 11% while European equities have only lost 3%. With the US debt ceiling debate continuing and likely leading to a compromise which will include a reducing in the current US deficit then 2023/24 could become a period of lower government growth impulse in the US compared to a bigger impulse in Europe. In other words, European equities offer a better earnings outlook on top of a much lower starting point in terms of valuation. What is not to like?

US vs European equities | Source: Bloomberg

Earnings estimate upgrades highlight Europe’s momentum

It is not only in terms of performance that Europe is shining these days. When we look at 12-month earnings estimates then analysts have been consistently more optimistic about European earnings. The 12-month earnings estimate on STOXX 600 is up 1.7% this year while the S&P 500 earnings estimate is down 0.1% this year. One of the underlying forces is the demand on the physical world is outstripping demand on the digital world as the fragmentation of global supply chains is driving enormous amount of investments in the US and Europe. But what is more impressive about the performance by European companies is that it is done with a less fiscal impulse compared to the US where the fiscal deficit is around 7% of GDP while Europe is closer to 3.5%. The war in Ukraine has accelerated two powerful forces in Europe, 1) the green transformation which is driving the biggest electrification the world has ever seen, and 2) a doubling of military spending which will cause positive second order effects into Europe’s industry.

The European equity stars in 2023

While the US equity market is driven by the technology and health care sector, the European equity market is more diversified across consumer sectors, health care, financials, and energy. The table below shows the 20 European stocks that have contributed the most to this year’s performance. Out of the 14% total return this year in the STOXX 600 Index, 5.75%-point of that performance have come from 20 stocks which we call the stars of Europe this year.

Three of these companies are within the roaring luxury theme which we have written extensively on during the year and recent as last week in our equity note Luxury stocks do not care about China’s old economy. Luxury stocks led by the French luxury giant LVMH have been the preferred way to express a positive view on the Chinese reopening. Outside luxury stocks, there are three health care stocks (Novo Nordisk, Novartis, and AstraZeneca) that have helped pull the index higher this year. Health care stocks have incredibly high quality and defensive characteristics that are in high demand amid the uncertainty over the economy and inflation. The procyclical boom in infrastructure, green transformation, and the de-risking of supply chains have benefitted industrial and semiconductor companies such as ASML, Siemens, and Schneider Electric; read our equity note from yesterday on the booming demand for electric grid infrastructure in Europe.

On the top 20 list we also find European banks such as HSBC and UniCredit. While there was a brief banking crisis due to the failure of Silicon Valley Bank it has failed to materialise into anything here in Europe except for the merger between UBS and Credit Suisse. European banks have been a positive story this year with expanding net interest income and lower than expected loan loss provisions. US banks have underperformed European banks by a wide margin the past year as explained in our recent equity note Equity update: US banks, European earnings, and Apple earnings.

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.